Abstract
21 patients with soft tissue sarcomas were treated after surgery with adriamycin alone or in combination with other drugs. 13 patients had additional local radiotherapy. 12 of the 21 patients received chemotherapy as an adjuvant to surgery. 19 patients concurrently receiving palliative treatment for advanced soft tissue sarcoma in the form of adriamycin and adriamycin combinations served as controls. Results collected to date point to an improvement in the prognosis of soft tissue sarcomas, when radical surgery is followed by intensive subsequent cytostatic treatment. However, the present results await confirmation from prospective randomized studies now taking place. Some of the side effects of this treatment were very pronounced and led to the premature interruption of the trial in 24% of cases.
| Original language | German |
|---|---|
| Pages (from-to) | 374-379 |
| Number of pages | 6 |
| Journal | Schweizerische Medizinische Wochenschrift |
| Volume | 110 |
| Issue number | 10 |
| Publication status | Published - 1980 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
ADJUVANTE CHEMOTHERAPIE BEI WEICHTEILSARKOMEN. / Tieche, M.; Goldhirsch, A.; Brunner, K. W.
In: Schweizerische Medizinische Wochenschrift, Vol. 110, No. 10, 1980, p. 374-379.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - ADJUVANTE CHEMOTHERAPIE BEI WEICHTEILSARKOMEN
AU - Tieche, M.
AU - Goldhirsch, A.
AU - Brunner, K. W.
PY - 1980
Y1 - 1980
N2 - 21 patients with soft tissue sarcomas were treated after surgery with adriamycin alone or in combination with other drugs. 13 patients had additional local radiotherapy. 12 of the 21 patients received chemotherapy as an adjuvant to surgery. 19 patients concurrently receiving palliative treatment for advanced soft tissue sarcoma in the form of adriamycin and adriamycin combinations served as controls. Results collected to date point to an improvement in the prognosis of soft tissue sarcomas, when radical surgery is followed by intensive subsequent cytostatic treatment. However, the present results await confirmation from prospective randomized studies now taking place. Some of the side effects of this treatment were very pronounced and led to the premature interruption of the trial in 24% of cases.
AB - 21 patients with soft tissue sarcomas were treated after surgery with adriamycin alone or in combination with other drugs. 13 patients had additional local radiotherapy. 12 of the 21 patients received chemotherapy as an adjuvant to surgery. 19 patients concurrently receiving palliative treatment for advanced soft tissue sarcoma in the form of adriamycin and adriamycin combinations served as controls. Results collected to date point to an improvement in the prognosis of soft tissue sarcomas, when radical surgery is followed by intensive subsequent cytostatic treatment. However, the present results await confirmation from prospective randomized studies now taking place. Some of the side effects of this treatment were very pronounced and led to the premature interruption of the trial in 24% of cases.
UR - http://www.scopus.com/inward/record.url?scp=0018898373&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018898373&partnerID=8YFLogxK
M3 - Articolo
VL - 110
SP - 374
EP - 379
JO - Schweizerische Medizinische Wochenschrift
JF - Schweizerische Medizinische Wochenschrift
SN - 0036-7672
IS - 10
ER -